Xvivo Perfusion AB(SE:XVIVO)
kr 206.00+3.20 (+1.58%)
SE:XVIVO
Xvivo Perfusion AB financials statements
kr 206.00
At close:+3.20 (+1.58%)
Want to see SE:XVIVO full AI Analyst Report?
Xvivo Perfusion AB (XVIVO) Financial Statements
4 Followers
Xvivo Perfusion AB Financial Overview
Xvivo Perfusion AB's market cap is currently kr6.49B. The company's EPS TTM is kr4.09; its P/E ratio is 50.37; Xvivo Perfusion AB is estimated to report earnings on January 28, 2027, and the estimated EPS forecast is kr0.87. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 812.16M | kr 822.41M | kr 597.54M | kr 415.29M | kr 258.39M |
| Gross Profit | kr 533.50M | kr 616.41M | kr 445.11M | kr 296.96M | kr 188.28M |
| Operating Income | kr 93.02M | kr 88.35M | kr 4.19M | kr 23.18M | kr 6.98M |
| EBITDA | kr 153.14M | kr 272.97M | kr 35.05M | kr 65.58M | kr 39.20M |
| Net Income | kr 25.16M | kr 172.18M | kr 91.82M | kr 18.43M | kr 8.15M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 292.09M | kr 415.52M | kr 546.09M | kr 246.54M | kr 398.70M |
| Total Assets | kr 2.37B | kr 2.40B | kr 2.20B | kr 1.73B | kr 1.54B |
| Total Debt | kr 124.72M | kr 34.04M | kr 31.44M | kr 10.01M | kr 5.72M |
| Net Debt | kr -167.37M | kr -381.48M | kr -514.35M | kr -236.54M | kr -392.98M |
| Total Liabilities | kr 260.65M | kr 245.97M | kr 250.57M | kr 302.95M | kr 257.15M |
| Stockholders' Equity | kr 2.11B | kr 2.16B | kr 1.95B | kr 1.43B | kr 1.29B |
| Cash Flow | |||||
| Free Cash Flow | kr -151.84M | kr -81.86M | kr -97.65M | kr -103.09M | kr -106.13M |
| Operating Cash Flow | kr 101.07M | kr 111.29M | kr 46.29M | kr 27.86M | kr -12.06M |
| Investing Cash Flow | kr -258.41M | kr -243.81M | kr -161.62M | kr -197.62M | kr -187.70M |
| Financing Cash Flow | kr 72.25M | kr -10.90M | kr 418.55M | kr -6.84M | kr 234.61M |
Currency in SEK
